|
|
|||
|
||||
OverviewA Primer on Prostate Cancer, The Empowered Patient's GuideA] is a basic resource to be used by patients and physicians when there has been a diagnosis of prostate cancer. It outlines a strategy of disease management that is designed to maximize outcomes for the patient and his loved ones. All aspects of diagnosis and testing are discussed; all currently approved treatments for prostate cancer are described. Discussion of treatment options includes information on side effects and includes questions the patient may not think to ask his doctor. Discussions of various treatments include the salvage therapies that might be employed if primary treatment fails. There is an extensive section on the theory and practice of androgen deprivation therapy in its various forms, since many patients have need of this type of information. There is a discussion of Treatments on the Horizon for the patient who is interested in the ongoing research in the world of prostate cancer. This is a current, comprehensive guide to prostate cancer presented in understandable terms with a user-friendly color format that will help the reader educate himself about prostate cancer. The book strives to help patients and their loved ones to combat ignorance and fear, replacing that with the empowerment of education. Full Product DetailsAuthor: Stephen B. Strum, MD , Donna PoglianoPublisher: Life Extension Media,U.S. Imprint: Life Extension Media,U.S. Edition: 2nd Revised edition Dimensions: Width: 21.50cm , Height: 1.80cm , Length: 14.00cm Weight: 0.588kg ISBN: 9780965877770ISBN 10: 0965877779 Pages: 124 Publication Date: 01 February 2005 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: No Longer Our Product Availability: Awaiting stock The supplier is currently out of stock of this item. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out for you. Table of ContentsReviewsAuthor InformationDr. Stephen B. Strum began his medical oncology practice in 1973. He collaborated with Dr. Fernand Labrie in 1983 on the use of combined androgen blockade in the treatment of prostate cancer-six years prior to FDA approval of Eulexin (flutamide) and Lupron (leoprolide). As a result of this pioneering work, his entire oncology practice was soon focused solely on prostate cancer. Tab Content 6Author Website:Countries AvailableAll regions |